a. Amino acid sequence alignment of MLX phosphorylation sites across different animal species.
b. MLX phosphorylation in 3rd instar control or mlx null (mlx1) larvae complemented with fat body-specific expression of mouse MLX-WT or MLX-A (mMlx-WT or mMlx-A, respectively). ACTIN serves as a loading control. n=3.
c. Pupariation of control, mlx1, mMlx-WT or mMlx-A larvae grown in low sugar diet (LSD, 10% yeast). N=4.
d. Survival of control, mlx1, mMlx-WT or mMlx-A larvae grown on LSD or high sugar diet (HSD, 10% yeast and 15% sucrose). Two-way ANOVA ****p<0.0001, ns=not significant. N=4.
e. Pupariation of control, mlx1, mMlx-WT or mMlx-A larvae grown on HSD. N=4.
f. Triglyceride (TAG) levels of 3rd instar control, mlx1, mMlx-WT or mMlx-A larvae grown on LSD or medium sugar diet (MSD, 10% yeast and 5% sucrose). Two-way ANOVA *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, ns=not significant. N=3.
g. Neutral lipid staining of the fat body in 3rd instar control, mlx1, mMlx-WT or mMlx-A larvae grown in LSD or MSD. n=5.
h. Hemolymph trehalose levels in 3rd instar control, mlx1, mMlx-WT or mMlx-A larvae in LSD or MSD. Two-way ANOVA *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, ns=not significant. N=3.